Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin
Sponsor: Johns Hopkins University
Summary
This study will evaluate the subjective and behavioral effects of psilocybin relative to placebo and alcohol.
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2027-03-01
Completion Date
2030-06-30
Last Updated
2026-10-16
Healthy Volunteers
Yes
Conditions
Interventions
0mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink
Participants will self-administer a capsule containing 0mg psilocybin and a drink that contains alcohol dosed to 0.00% BAC.
1mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink
Participants will self-administer a capsule containing 1mg psilocybin and a drink that contains alcohol dosed to 0.00% BAC.
5mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink
Participants will self-administer a capsule containing 5mg psilocybin and a drink that contains alcohol dosed to 0.00% BAC.
15mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink
Participants will self-administer a capsule containing 15mg psilocybin and a drink that contains alcohol dosed to 0.00% BAC.
25mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink
Participants will self-administer a capsule containing 25mg psilocybin and a drink that contains alcohol dosed to 0.00% BAC.
0mg Psilocybin Capsule + 0.08% BAC Alcoholic Drink
Participants will self-administer a capsule containing 0mg psilocybin and a drink that contains alcohol dosed to 0.08% BAC.
Locations (1)
Johns Hopkins University
Baltimore, Maryland, United States